| Original language | English (US) |
|---|---|
| Pages (from-to) | 1577-1578 |
| Number of pages | 2 |
| Journal | Journal of the American College of Cardiology |
| Volume | 60 |
| Issue number | 16 |
| DOIs | |
| State | Published - Oct 16 2012 |
| Externally published | Yes |
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Are racial/ethnic gaps in the use of cardiac resynchronization therapy narrowing? An analysis of 107,096 patients from the national cardiovascular data registry's ICD registry. / Eapen, Zubin J.; Al-Khatib, Sana; Lopes, Renato D. et al.
In: Journal of the American College of Cardiology, Vol. 60, No. 16, 16.10.2012, p. 1577-1578.Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - Are racial/ethnic gaps in the use of cardiac resynchronization therapy narrowing? An analysis of 107,096 patients from the national cardiovascular data registry's ICD registry
AU - Eapen, Zubin J.
AU - Al-Khatib, Sana
AU - Lopes, Renato D.
AU - Wang, Yongfei
AU - Bao, Haikun
AU - Curtis, Jeptha
AU - Heidenreich, Paul A.
AU - Hernandez, Adrian F.
AU - Peterson, Eric D.
AU - Hammill, Stephen C.
N1 - Funding Information: Please note: This work was supported by an award from the American Heart Association Pharmaceutical Roundtable and David and Stevie Spina. Dr. Eapen has received funding from an American Heart Association Pharmaceutical Roundtable outcomes training grant ( 0875142N ). Dr. Lopes has received funding for a research grant from Bristol-Myers Squibb (significant). Dr. Al-Khatib has received modest speaking fees from Medtronic Inc. Dr. Curtis has received stock holding in Medtronic Inc. (significant); research funding from Boston Scientific (significant); and salary support from the American College of Cardiology National Cardiovascular Data Registry (significant). Dr. Heidenreich is an uncompensated consultant to Boston Scientific. Dr. Hernandez has received research funding from Johnson & Johnson and Amylin Pharmaceuticals, Inc. (>$10,000) and honorarium from Sanofi Aventis, AstraZeneca, Johnson & Johnson, and Corthera, Inc. (<$10,000). Dr. Peterson has received grant support from Eli Lilly and Company , Johnson & Johnson, and Janssen Pharmaceuticals . All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
PY - 2012/10/16
Y1 - 2012/10/16
UR - http://www.scopus.com/inward/record.url?scp=84867400776&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84867400776&partnerID=8YFLogxK
U2 - 10.1016/j.jacc.2012.06.024
DO - 10.1016/j.jacc.2012.06.024
M3 - Letter
C2 - 22958954
AN - SCOPUS:84867400776
SN - 0735-1097
VL - 60
SP - 1577
EP - 1578
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
IS - 16
ER -